D, G., L, B., E, L., J, M., G, C., S, P., . . . CV, C. (2017). Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 114(25), E4924. https://doi.org/10.1073/pnas.1615730114
Chicago Style (17th ed.) CitationD, Genini, et al. "Mitochondrial Dysfunction Induced by a SH2 Domain-targeting STAT3 Inhibitor Leads to Metabolic Synthetic Lethality in Cancer Cells." Proceedings of the National Academy of Sciences of the United States of America 114, no. 25 (2017): E4924. https://doi.org/10.1073/pnas.1615730114.
MLA (9th ed.) CitationD, Genini, et al. "Mitochondrial Dysfunction Induced by a SH2 Domain-targeting STAT3 Inhibitor Leads to Metabolic Synthetic Lethality in Cancer Cells." Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 25, 2017, p. E4924, https://doi.org/10.1073/pnas.1615730114.
